Maurice and Vivienne Wohl Institute for Drug Discovery

Drug Discovery Team

Dr. Haim Barr
Head of the Maurice and Vivienne Wohl Institute for Drug Discovery
Dr. Haim Barr
Head of the Maurice and Vivienne Wohl Institute for Drug Discovery

Dr. Haim Barr completed his Ph.D. studies in the Technion – Israel Institute of Technology in 2001 and then pursued a career in biotechnology for 11 years. Coming from academic studies in the fields of ubiquitin and phosphatase biology, Haim initially was a research group leader and then lead drug discovery efforts in Proteologics Ltd. In those years, Proteologics successfully transferred from target to small molecule discovery with a unique and automated integration of in vitro ubiquitination assays which has become the backbone of the company’s activities. Subsequently, Haim joined BiolineRx Ltd. where he specialized in recruitment and management of early-phase projects from Israeli and international academic labs for translation into industrial/clinical development. In addition to Haim’s basic science and automation skills, he has been involved in bio-industrial business development for several years, where he served as in-licensing manager in BiolineRx.

Dr. Alexander Plotnikov
Project leader
Dr. Alexander Plotnikov
Project leader
Dr. Noga Kozer Gourevich
Project leader, High Content Imaging
Dr. Noga Kozer Gourevich
Project leader, High Content Imaging
Dr. Silvia Carvalho
Lab Technician
Dr. Silvia Carvalho
Lab Technician
Galit Cohen, BSc.
Compound Management
Galit Cohen, BSc.
Compound Management
Gabriel Amitai
Consultant
Gabriel Amitai
Consultant